Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で94.92%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 32.63Mに達しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 32.63Mです。
割安
同社の最新のPEは-49.97で、過去3年間の水準と比較して安値圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は4.37M株で、前四半期比で11.47%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を445.21K株保有しています。